Core Laboratories (CLB) Debt to Equity (2022 - 2026)

Core Laboratories has reported Debt to Equity for 5 years, with the latest figure at $0.42 in Q1 2026.

• For the quarter ending Q1 2026, Debt to Equity fell 15.06% year-over-year to $0.42; the trailing twelve-month figure through Mar 2026 stood at $0.42 (down 15.06% YoY), and the FY2025 full-year result was $0.41, down 17.07% from the prior year.
• Debt to Equity for Q1 2026 stood at $0.42, roughly flat from $0.41 in the prior quarter.
• The five-year high for Debt to Equity was $0.94 in Q4 2022, with the low at $0.41 in Q4 2025.
• Historically, Debt to Equity has averaged $0.6 across 5 years, with a median of $0.55 in 2024.
• Annual changes were most pronounced in 2024 — Debt to Equity tumbled 31.25% — and 2026, when it decreased 15.06%.
• Core Laboratories' Debt to Equity stood at $0.94 in 2022, then decreased by 22.6% to $0.73 in 2023, then plunged by 31.25% to $0.5 in 2024, then retreated by 17.07% to $0.41 in 2025, then increased by 0.36% to $0.42 in 2026.
• The last three Debt to Equity figures came in at $0.42 (Q1 2026), $0.41 (Q4 2025), and $0.42 (Q3 2025), per Business Quant data.